Cheng Chen

Cheng Chen

Scientist Ii @ CytomX Therapeutics

About Cheng Chen

Cheng Chen is a Scientist II at CytomX Therapeutics, with a background in Biological Sciences and extensive experience in drug characterization and analytical method development. He has previously held positions at Dynavax Technologies and Cornell University, contributing to regulatory filings and various analytical techniques.

Work at CytomX Therapeutics

Cheng Chen has been employed at CytomX Therapeutics as a Scientist II since 2019. In this role, he contributes to the development and characterization of drug substances and products. His responsibilities include conducting stability and comparability studies, as well as supporting regulatory filings such as Investigational New Drug (IND) applications and Biologics License Applications (BLA). His expertise in analytical method development and validation, particularly for monoclonal antibodies, is integral to the company's research and development efforts.

Education and Expertise

Cheng Chen holds a Ph.D. in Biochemistry, Molecular Biology, and Genetics from Cornell University. He also earned a B.S. in Biological Sciences from Fudan University and studied Biological Sciences at The Hong Kong University of Science and Technology. His educational background provides a strong foundation for his expertise in analytical method development and validation, particularly for monoclonal antibodies. He is proficient in various analytical techniques, including CE-SDS, HPLC, ELISA, and amino acid analysis.

Background

Cheng Chen's professional background includes significant experience in the biotechnology sector. Prior to his current position, he worked at Dynavax Technologies, where he held roles as a Senior Postdoctoral Fellow, Scientist I, and Scientist II from 2015 to 2019. He also served as a Research Assistant at Cornell University, where he was involved in protein biochemistry, molecular biology, and gene regulation. His early academic experience includes roles as a Teaching Assistant and Student Staff at Cornell University.

Achievements

Throughout his career, Cheng Chen has been involved in various aspects of drug substance and product characterization. He has experience in setting and revising specifications, generating Certificates of Analysis (CoAs), and conducting Out of Specification (OOS) and Out of Trend (OOT) investigations. His work supports regulatory compliance and includes the implementation of Corrective and Preventive Actions (CAPA). His contributions have been crucial in advancing the research and development of biopharmaceutical products.

People similar to Cheng Chen